Document is current

Any future updates will be listed below

Correction: Corrigendum: Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1038/srep09548

Published Online: 2015-08-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark